Impact of oral cyclophosphamide on health‐related quality of life in patients with active scleroderma lung disease: Results from the scleroderma lung study - Concepedia

Concepedia

Publication | Open Access

Impact of oral cyclophosphamide on health‐related quality of life in patients with active scleroderma lung disease: Results from the scleroderma lung study

DOI Full Paper Access

96

Citations

41

References

2007

Year

Dinesh Khanna, Xiaohong Yan, Donald P. Tashkin, Daniel E. Furst, Robert M. Elashoff, Michael D. Roth, Richard M. Silver, Charlie Strange, Marcy B. Bolster, James R. Seibold,

Arthritis & Rheumatism

Abstract

One year of treatment with CYC leads to an improvement in HRQOL in patients with scleroderma lung disease.

References

	Year	Citations

Page 1